Have a new drug that promises to fight Covid-19? The FDA promises fast action but some developers aren't happy
After providing an emergency approval to use malaria drugs against coronavirus with little actual evidence of their efficacy or safety in that setting, the FDA has already proven that it has set aside the gold standard when it comes to the pandemic. And now regulators have spelled out a new approach to speeding development that promises immediate responses in no uncertain terms — promising a program offering the ultimate high-speed pathway to Covid-19 drug approvals.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 82,500+ biopharma pros reading Endpoints daily — and it's free.